Human papillomavirus in cervical screening and vaccination

被引:20
|
作者
Crosbie, Emma J. [1 ]
Kitchener, Henry C. [1 ]
机构
[1] Univ Manchester, St Marys Hosp, Acad Univ Obstet & Gynaecol, Manchester M13 0JH, Lancs, England
来源
CLINICAL SCIENCE | 2006年 / 110卷 / 05期
关键词
cervical cancer; cervical intraepithelial neoplasia; cervical screening; human papillomavirus (HPV); prophylactic vaccination; therapeutic vaccination;
D O I
10.1042/CS20050230
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent decades have witnessed a reduction in the incidence of cervical cancer in countries where screening programmes have achieved broad coverage. The recognized importance of high-risk HPV (human papillomavirus) infection in the aetiology of cervical cancer may introduce a role for HPV DNA testing in cervical screening programmes. Positive HPV DNA tests indicate women at risk of cervical cancer with greater sensitivity, but reduced specificity, compared with exfoliative cytology. Combining HPV testing with cytology may be useful in the triage of minor cytological abnormalities into those requiring referral to colposcopy (HPV positive) compared with those who can be safely managed by cytological surveillance (HPV negative). With its high sensitivity and high-negative-predictive value, HPV testing may also be useful for predicting treatment failure, since residual disease is very unlikely in the event of a negative HPV test. Ultimately, prevention is better than cure, and the advent of HPV prophylactic vaccines may obviate the need for population-based cervical screening programmes in the future. A multivalent vaccine administered to adolescents prior to the onset of sexual activity and boosted at regular intervals throughout their sexually active life may provide protection against type-specific HPV infection, malignant precursors and invasive cervical disease. Several large randomized placebo-controlled trials have been conducted with promising results. For those generations of women already exposed to high-risk HPV infection, therapeutic vaccines may offer advantages over conventional treatment, although much work still needs to be done.
引用
收藏
页码:543 / 552
页数:10
相关论文
共 50 条
  • [1] Human papillomavirus vaccination - Paradox of vaccination in cervical cancer and screening
    Gericke, Christian A.
    [J]. BRITISH MEDICAL JOURNAL, 2008, 337 (7664):
  • [2] Models of cervical screening in the era of human papillomavirus vaccination
    Canfell, Karen
    [J]. SEXUAL HEALTH, 2010, 7 (03) : 359 - 367
  • [3] Screening for Cervical Cancer and Human Papillomavirus Vaccination in Israel: Recommendations
    Bornstein, Jacob
    Fisher, William A.
    Ginsberg, Gary M.
    Shavit, Oren
    Schejter, Eduardo
    Diaz, Mireia
    Xavier Bosch, F.
    [J]. VACCINE, 2013, 31 : 58 - 60
  • [4] Cervical Cancer Screening in the Era of Human Papillomavirus Testing and Vaccination
    Murphy, Jeanne
    Mark, Hayley
    [J]. JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2012, 57 (06) : 569 - 576
  • [5] Cervical cancer screening following prophylactic human papillomavirus vaccination
    Franco, Eduardo L.
    Cuzick, Jack
    [J]. VACCINE, 2008, 26 : A16 - A23
  • [6] Effect of human papillomavirus vaccination on cervical cancer screening in Alberta
    Kim, Jong
    Bell, Christopher
    Sun, Maggie
    Kliewer, Gordon
    Xu, Linan
    McInerney, Maria
    Svenson, Lawrence W.
    Yang, Huiming
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (12) : E281 - E288
  • [7] Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results
    Castle, Philip E.
    Xie, Xianhong
    Xue, Xiaonan
    Poitras, Nancy E.
    Lorey, Thomas S.
    Kinney, Walter K.
    Wentzensen, Nicolas
    Strickler, Howard D.
    Burger, Emily A.
    Schiffman, Mark
    [J]. PREVENTIVE MEDICINE, 2019, 118 : 44 - 50
  • [8] Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination
    Zhu, Yusheng
    Wang, Yun
    Hirschhorn, Julie
    Welsh, Kerry J.
    Zhao, Zhen
    Davis, Michelle R.
    Feldman, Sarah
    [J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 81, 2017, 81 : 135 - 192
  • [9] Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria
    Barbaro, Bianca
    Brotherton, Julia M. L.
    Gertig, Dorota M.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (07) : 445 - 445
  • [10] Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment
    Cecilia Rodriguez, Ana
    Solomon, Diane
    Herrero, Rolando
    Hildesheim, Allan
    Gonzalez, Paula
    Wacholder, Sholom
    Porras, Carolina
    Jimenez, Silvia
    Schiffman, Mark
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (05) : 752 - 760